The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...

Leerink Partnrs cut their FY2024 earnings estimates for shares of Recursion Pharmaceuticals in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now expects that ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,172 calls trading, 4x expected, and implied vol increasing almost 7 ...

Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...

Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.49 which represents a slight increase of $0.61 or 8.87% from the prior close of $6.88. The stock opened at $7.17 ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

During a speech at the White House on Tuesday, Ellison emphasized AI's ability to detect cancer early through blood tests and its crucial role in creating individualized vaccines rapidly. This ...

Investors looking for stocks that could make dramatic moves in a short, defined time frame will want to turn their attention ...

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 17, 2025 /PRNewswire/ -- According to experts, soon the integration of artificial intelligence ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.